Phenoxybenzamine Hydrochloride Capsule
Product Images NDC 59651-327

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Phenoxybenzamine Hydrochloride (NDC 59651-327). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1 (Phenoxybenzamine Fig1)

Fig1 (Phenoxybenzamine Fig1)
Packaging label for Phenoxybenzamine Hydrochloride Capsules, USP 10 mg, a drug for further processing supplied by Aurobindo Pharma Limited. The label indicates each capsule contains 10 mg of the active ingredient, includes storage instructions at 20° to 25°C, and notes a package count of 100 capsules. Distributed by Aurobindo Pharma USA, Inc., with manufacturing in India.*
FDA Label Image

Str (Phenoxybenzamine Str)

Str (Phenoxybenzamine Str)
Chemical structure of Phenoxybenzamine Hydrochloride, showing its molecular components and arrangement, including aromatic rings and side chains as depicted in the diagram.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.